SOHU [SOHU COM] SC 13G: (Original Filing)

[CUSIP No. 83408W103 1. Names of Reporting Persons Macquarie Group Limited 2. Check the Appropriate Box if a Member of a Group (See Instructions) x ¨ (a) 3. SEC Use Only 4. Citizenship or Place of Organization Sydney, New South Wales Australia Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting]

SOHU [SOHU COM] SC 13G: CUSIP No. 83408W103 1. Names of Reporting Persons

[CUSIP No. 83408W103 1. Names of Reporting Persons Macquarie Group Limited 2. Check the Appropriate Box if a Member of a Group (See Instructions) x ¨ (a) 3. SEC Use Only 4. Citizenship or Place of Organization Sydney, New South Wales Australia Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 0 6. Shared Voting]

SOHU [SOHU COM] SC 13G/A: (Original Filing)

[Common Stock 83408W103 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 83408W103 1 NAME]

SOHU [SOHU COM] SC 13G/A: Common Stock 83408W103 December 31, 2013 [X] Rule

[Common Stock 83408W103 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 83408W103 1 NAME]

EJ [E-HOUSE (CHINA)] SC 13G/A: (Original Filing)

[Ordinary shares, par value $0.001 per share 26852W103 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.]

EJ [E-HOUSE (CHINA)] SC 13G/A: Ordinary shares, par value $0.001 per share 26852W103

[Ordinary shares, par value $0.001 per share 26852W103 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.]

KANG [iKang Healthcare] DRSLTR: New York Menlo Park Washington DC São Paulo

[New York Menlo Park Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Li He LLP Davis Polk & Wardwell 2201 China World Office 2 1 Jian Guo Men Wai Avenue Chaoyang District Beijing 100004 86 10 8567 5005 tel 86 10 8567 5105 fax li.he@davispolk.com February 14, 2014 iKang Guobin Healthcare Group, Inc. Draft Registration Statement on]

KANG [iKang Healthcare] DRS/A: (Original Filing)

[CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP, INC. SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Guobin Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Guobin Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee th st Address: 701, 7 Party B: ID Number: 320102198102151619 Party C: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose of this Agreement, the Pledgee, Pledgors and Party C are individually referred to as “ Whereas:] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated February 14, 2014 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc. its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]

KANG [iKang Healthcare] DRS/A: CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP,

[CONFIDENTIAL TREATMENT REQUESTED BY IKANG GUOBIN HEALTHCARE GROUP, INC. SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Guobin Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Guobin Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee th st Address: 701, 7 Party B: ID Number: 320102198102151619 Party C: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose of this Agreement, the Pledgee, Pledgors and Party C are individually referred to as “ Whereas:] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated February 14, 2014 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc. its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012]

ZA [ZUOAN FASHION] SC 13G/A: (Original Filing)

[(Name of Issuer) Ordinary Shares, par value $0.00025 per ordinary share (Title of Class of Securities) 98982X103 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with]

Skip to toolbar